Needle Localization During Prostate Brachytherapy Using Power Doppler Ultrasound

Launched by WESTERN UNIVERSITY, CANADA · Feb 28, 2019

Keywords

ClinConnect Summary

This clinical trial is studying a new way to help doctors accurately place a special treatment called brachytherapy for prostate cancer. Brachytherapy involves inserting small radioactive seeds into the prostate to treat tumors. Traditionally, doctors use regular ultrasound images to guide the placement of the needles, but this study is testing a new technique using power Doppler ultrasound. This method allows the vibrations from a simple device attached to the needle to be seen on the ultrasound, potentially making it easier for doctors to see exactly where the needles are going.

To participate in this trial, you must be a man aged 18 or older who has been diagnosed with prostate cancer through a biopsy and is eligible for high-dose-rate brachytherapy. You also need to be willing to sign a consent form to take part. If you join the study, you can expect to receive standard care for your cancer treatment while helping researchers learn if this new imaging technique can improve the accuracy of needle placement during the procedure.

Gender

MALE

Eligibility criteria

• Inclusion Criteria:
• • Male, aged 18 years or older
• • Willing to provide written consent
• • Pathologically confirmed prostate cancer on previous biopsy
• • Suitable for and consenting to high-dose-rate brachytherapy for treatment as standard of care.
• Exclusion Criteria:
• • • Previous radiotherapy to the prostate